alexa The Efficacy Of Doxocycline, Rousovastatine And Spironolactone On Cardiotoxic Effect Of Doxorubicin In Female Albino Rats | 64290
ISSN: 2476-2067

Toxicology: Open Access
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

8th World Congress on Toxicology and Pharmacology

Ansam J Altelchy and Ansam N Al-Hassani
Hawler Medical University, Iraq
Posters & Accepted Abstracts: Toxicol Open Access
DOI: 10.4172/2476-2067.C1.003
Abstract
Background & Aim: Cardiotoxicity that is caused by chemotherapy is a devastating disorder that impairs the ability of the heart to respond to physiological demands for increased cardiac output that may result in heart failure. This led to the attempt of evaluating the efficacy of Doxycycline, Rosuvastatin and Spironolacton in Doxorubicin induced cardiotoxicity. The aims of this study are to assess the ability of these drugs to attenuate Doxorubicin induced heart failure in rats and to compare among them regarding their ability to cause remarkable structural, biochemical, and histopathological changes that preserve normal cardiac function. Methods: 46 female Albino rats, 8-12 weeks old, weighing 140-200 grams were used in the study. The animals were housed in groups of 8 and 10 per cage, on sawdust in the animal house facility, under conditions of controlled ambient temperature of 22-25ÂșC with a 12 hour light/ dark cycles. The animals were supplied with rodent chow and free access to tap water. They were divided in to 3 groups. The control group which included 8 rats, Doxorubicin group, included 8 rats and treatment group, each included 10 rats. All groups were treated for a period of 4 weeks. Mean serum (BNP), (CgA), (TC), (HDL), (LDL), (TG) and (UA) levels, in addition to the histopathological studies, are the estimated parameters used in this study. Results: All drugs used in the treatment group showed a degree of cardioprotection effect against Doxorubicin induced cardiotoxicity, and caused a significant reduction in mean serum BNP, CgA, total cholesterol, TG, LDL, and uric acid levels and increment in HDL as compared with Doxo group. While Spironolactone appeared to be inferior in amelioration the parameters that accompanied with cardiac toxicity was induced by Doxorubicin, than the other drugs in the treatment group. In conclusion, Rosuvastatine appeared to be the most beneficial in amelioration of Doxorubicin induced cardiac toxicity.
Biography

Ansam J Altelchy has finished her BSc Pharmacy in 2010. She has embarked on experiential job as a rotational Clinical Pharmacist at different hospitals. After one year of training and gaining experience, she was offered by Hawler Medical University to be a Demonstrator in pharmaceutical labs. She has obtained MSc degree in 2015 from Hawler Medical University- College of Pharmacy. She is currently holding a post of Assistant Lecturer in the Pharmacology and Toxicology Dept. in the same University and is interested in pursuing PhD in the near future.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7